Abstract
The authors are currently conducting molecular and genetic research to identify new targets for therapeutic interventions and predictive biomarkers in pseudomyxoma peritonei. The final aim of these studies is to rationalize the choice of treatment, which remains an unmet clinical need.
Cite
CITATION STYLE
APA
Baratti, D., Kusamura, S., Maggi, C., Braud, F., Deraco, M., Di Bartolomeo, M., & Pietrantonio, F. (2015). In Reply. The Oncologist, 20(3), e5–e5. https://doi.org/10.1634/theoncologist.2014-423
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free